| ASSET | QUARTER | % RETURN |
|---|---|---|
Arena (AREN) | Q2 2004 | 16,357.26% |
Oramed Pharmaceuticals (ORMP) | Q2 2004 | 11,925.44% |
Oragenics (OGEN) | Q1 2004 | 1,856.18% |
Xcel Brands (XELB) | Q4 2004 | 1,325% |
Theriva Biologics (TOVX) | Q4 2004 | 900% |
NeoGenomics (NEO) | Q1 2004 | 800.4% |
Lightbridge (LTBR) | Q4 2004 | 723.53% |
ACCESS Newswire (ACCS) | Q1 2004 | 699.89% |
Cemtrex (CETX) | Q2 2004 | 600.55% |
Lifevantage (LFVN) | Q3 2004 | 445.45% |
Inuvo (INUV) | Q1 2004 | 432.61% |
Denny’s (DENN) | Q1 2004 | 409.52% |
Ammo (POWW) | Q1 2004 | 400% |
Worksport (WKSP) | Q2 2004 | 292.16% |
Dmc Global (BOOM) | Q4 2004 | 287.89% |
Aethlon Medical (AEMD) | Q1 2004 | 264.86% |
Travelzoo (TZOO) | Q2 2004 | 259.35% |
Inseego (INSG) | Q1 2004 | 257.74% |
Widepoint C (WYY) | Q1 2004 | 253.85% |
Insteel Industries (IIIN) | Q2 2004 | 244.04% |
Repro Med Systems (KRMD) | Q1 2004 | 237.5% |
Nocera (NCRA) | Q2 2004 | 233.33% |
AlphaTON Capital (ATON) | Q4 2004 | 233.33% |
Lifeway Foods (LWAY) | Q1 2004 | 227.67% |
Cogent Communications (CCOI) | Q4 2004 | 227.27% |
